Literature DB >> 17433255

Identification of the auto-inhibitory domains of Aurora-A kinase.

Yue Zhang1, Jun Ni, Qiang Huang, Weihua Ren, Long Yu, Shouyuan Zhao.   

Abstract

Aurora-A is a centrosome-localized serine/threonine kinase that is overexpressed in multiple human cancers. Here, we report an intramolecular inhibitory regulation in Aurora-A between its N-terminal regulatory domain (aa 1-128, Nt) and the C-terminal catalytic domain (aa 129-403, Cd). Removal of Nt results in a significant increase in kinase activity. Nt inhibited the activity of the single C-terminal kinase domain, but had little effect on the activity of the full-length of Aurora-A. PP1 is not involved in this regulation, instead, Nt interacts Cd directly in vitro and in vivo. The non-Aurora box (aa 64-128) in the N-terminal negatively regulated the kinase activity of the C-terminal kinase domain by intramolecular interaction with aa 240-300 within the C-terminal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433255     DOI: 10.1016/j.bbrc.2007.03.129

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Insights into the non-mitotic functions of Aurora kinase A: more than just cell division.

Authors:  Giulia Bertolin; Marc Tramier
Journal:  Cell Mol Life Sci       Date:  2019-09-27       Impact factor: 9.261

2.  RACK1 affects the progress of G2/M by regulating Aurora-A.

Authors:  Suqin Shen; Huan Feng; Yichen Le; Jun Ni; Long Yu; Jiaxue Wu; Meirong Bai
Journal:  Cell Cycle       Date:  2019-07-29       Impact factor: 4.534

3.  ARD1-mediated aurora kinase A acetylation promotes cell proliferation and migration.

Authors:  Tam Thuy Lu Vo; Ji-Hyeon Park; Ji Hae Seo; Eun Ji Lee; Hoon Choi; Sung-Jin Bae; Hoang Le; Sunho An; Hye Shin Lee; Hee-Jun Wee; Kyu-Won Kim
Journal:  Oncotarget       Date:  2017-07-18

Review 4.  The multifaceted allosteric regulation of Aurora kinase A.

Authors:  Nicholas Mark Levinson
Journal:  Biochem J       Date:  2018-06-26       Impact factor: 3.857

5.  Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells.

Authors:  Warren Fiskus; Yongchao Wang; Rajeshree Joshi; Rekha Rao; Yonghua Yang; Jianguang Chen; Ravindra Kolhe; Ramesh Balusu; Kelly Eaton; Pearl Lee; Celalettin Ustun; Anand Jillella; Carolyn A Buser; Stephen Peiper; Kapil Bhalla
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 6.  On the molecular mechanisms of mitotic kinase activation.

Authors:  Richard Bayliss; Andrew Fry; Tamanna Haq; Sharon Yeoh
Journal:  Open Biol       Date:  2012-11       Impact factor: 6.411

7.  Aurora-A kinase-inactive mutants disrupt the interaction with Ajuba and cause defects in mitotic spindle formation and G2/M phase arrest in HeLa cells.

Authors:  Meirong Bai; Jun Ni; Suqin Shen; Qiang Huang; Jiaxue Wu; Yichen Le; Long Yu
Journal:  BMB Rep       Date:  2014-11       Impact factor: 4.778

Review 8.  Ubiquitin-Mediated Degradation of Aurora Kinases.

Authors:  Catherine Lindon; Rhys Grant; Mingwei Min
Journal:  Front Oncol       Date:  2016-01-18       Impact factor: 6.244

9.  A FRET biosensor reveals spatiotemporal activation and functions of aurora kinase A in living cells.

Authors:  Giulia Bertolin; Florian Sizaire; Gaëtan Herbomel; David Reboutier; Claude Prigent; Marc Tramier
Journal:  Nat Commun       Date:  2016-09-14       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.